Cas No.: | 154235-83-3 |
Chemical Name: | Ampalex |
Synonyms: | Piperidin-1-yl(quinoxalin-6-yl)methanone;1-(Quinoxalin-6-ylcarbonyl)piperidine;Piperidin-1-yl-quinoxalin-6-ylmethanone;Ampalex;ABT-224;Ampakine CX516;BDP 12;CX516;CX-516;PIPERIDINE, 1-(6-QUINOXALINYLCARBONYL)-;1-Piperidinyl-6-quinoxalinyl-methanone;6-(Piperidin-1-ylcarbonyl)quinoxaline;AMpalex (CX-516);SPD-420, BDP-12, CX-516, AMpalex;1-(6-Quinoxalinylcarbonyl)piperidine;1-Piperidinyl-6-quinoxalinylMethanone;BDP-12;BDP-12;;CX 516;Ampalex, >=98%;6-(piperidine-1-carbonyl)quinoxaline;1-piperidyl(quinoxalin-6-yl)methanone;Z5QU38B4V9;Piperidin-1-yl-quinoxalin-6-yl-methanone;1-(6-quinoxalinylcarbonyl)-Piperidine;PubChem |
SMILES: | O=C(C1C([H])=C([H])C2C(C=1[H])=NC([H])=C([H])N=2)N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] |
Formula: | C14H15N3O |
M.Wt: | 241.2884 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). |